Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Sort descending Journal Bone Marrow Disease
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial Lancet Myelodysplastic Syndromes (MDS)
TERC haploid cell reprogramming: a novel therapeutic strategy for aplastic anemia Molecular Medicine Aplastic Anemia
Are we ready to ring in a new upfront therapy in lower-risk myelodysplastic syndromes? Lancet Myelodysplastic Syndromes (MDS)
Pegcetacoplan controls hemolysis in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria Blood Advances Paroxysmal Nocturnal Hemoglobinuria (PNH)
IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria Blood Aplastic Anemia
Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia Blood Aplastic Anemia
Treatment of eculizumab refractory paroxysmal nocturnal hemoglobinuria: A systematic review about current treatment options and future direction SAGE Open Medicine Paroxysmal Nocturnal Hemoglobinuria (PNH)
Luspatercept use for lower risk myelodysplastic syndromes: Active but not enough American Journal of Hematology Myelodysplastic Syndromes (MDS)
Therapy-related myelodysplastic syndromes in the genomics era Bulletin du Cancer Myelodysplastic Syndromes (MDS)
Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study Blood Advances Myelodysplastic Syndromes (MDS)

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.